Masimo Corp

US

MASIX

Health Care

134.32 ₽

Current price

Strong sell
134.32 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    573 / 663

  • Position in country

    12910 / 14179

  • Return on Assets, %

    2.6

    -11.9

  • Net income margin, %

    6.1

    -12.5

  • EBITDA margin, %

    15.9

    -2.5

  • Debt to Equity, %

    66.3

    15

  • Intangible assets and goodwill, %

    34.8

    3.9

  • Revenue CAGR 3Y, %

    21.4

    12.6

  • Total Equity change 1Y, %

    1.9

    0

  • Revenue Y, % chg

    0.6

    4.6

  • P/E

    91.5

    28.3

  • P/BV

    5.3

    1.7

  • P/S

    3.5

    3.7

  • EV/S

    3.9

    3.2

  • EV/EBITDA

    30.4

    -0.2

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    13.2

    66.5

  • Forward P/E

    38

    19.2

  • Payout Ratio, %

    0

    17.3

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Becton Dickinson and Co

    00%

  • Masimo Corp

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    7297.7

  • Ticker

    MASI.O

  • ISIN

    US5747951003

  • IPO date

    2007-08-08

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-28

  • Date fact. publication of reports

    2023-12-30

Company Description

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive technologies and hospital automation solutions. Its patient monitoring solution that incorporates a monitor or circuit board, single-patient use or reusable sensors, software and cables. The Company’s main products include Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include noninvasive monitoring of blood constituents with an optical signature, optical regional oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain. It sells its products hospitals, emergency medical service (EMS) providers, home care providers, long-term care facilities, physician offices, veterinarians and consumers through direct sales force, distributors and original equipment manufacturers (OEM) partners.